跳至主要内容
临床试验/EUCTR2011-005243-28-SE
EUCTR2011-005243-28-SE进行中(未招募)1 期

A Phase 3b Multicenter, Open-label Abiraterone Acetate Long-term Safety Study

Janssen-Cilag International NV0 个研究点目标入组 31 人开始时间: 2017年1月10日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Currently participating in an abiraterone acetate clinical study considered complete and had received at least 3 months of treatment with abiraterone acetate tablets.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 117
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 183

排除标准

  • - Medical conditions that require hospitalization.
  • - Any condition or situation which, in the opinion of the investigator, may put the patient at significant risk, may confound the study results, or may interfere significantly with the patient's participation in the study.

研究者

相似试验

进行中(未招募)
不适用
A Study that Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateMetastatic Castration-Resistant Prostate Cancer (PCR)MedDRA version: 14.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2011-005243-28-DEJanssen-Cilag International NV300
进行中(未招募)
1 期
A Study that Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate.Metastatic Castration-Resistant Prostate Cancer (mCRPC) and metastatic high-risk castration/ hormone-sensitive prostate CancerMedDRA version: 20.0Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2011-005243-28-GBJanssen-Cilag International NV300
进行中(未招募)
不适用
A Study Examining Long-term Access to Abiraterone AcetateMetastatic Castration-Resistant Prostate Cancer (PCR)MedDRA version: 14.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2011-005243-28-ATJanssen-Cilag International NV300
进行中(未招募)
不适用
A Study Examining Long-term Access to Abiraterone Acetate
EUCTR2011-005243-28-HUJanssen-Cilag International NV300
进行中(未招募)
1 期
A Study Examining Long-term Access to Abiraterone Acetate
EUCTR2011-005243-28-ESJanssen-Cilag International NV31